PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: marketing

A Phase II Randomized, Double-Blinded, Controlled Study in ...

A Phase II Randomized, Double-Blinded, Controlled Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Influenza A/H7N9 Virus Vaccine Administered at Different Dosages Given With and Without MF59 AdjuvantDMID Protocol Number: 13-0032 DMID Funding Mechanism:Vaccine Treatment and Evaluation UnitsPharmaceutical Support:sanofi pasteurNovartis Vaccines and DiagnosticsIND Sponsor:Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of HealthLead Principal Investigator:Mark J. Mulligan, MD, FIDSADMID Clinical Project Manager: Wendy L.

A Phase II Randomized, Double-Blinded, Controlled Study in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Influenza A/H7N9 Virus …

Loading..

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of A Phase II Randomized, Double-Blinded, Controlled Study in ...

Related search queries